NCT05205486View on ClinicalTrials.gov

Pharmacokinetics and Safety of Cefazolin 3gm DUPLEX in Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 5, 2022

Primary Completion Date

July 13, 2023

Study Completion Date

July 13, 2023

Conditions
Infections
Interventions
DRUG

Cefazolin 3gm for Injection USP and Dextrose Injection USP

Cefazolin 3gm for Injection USP and Dextrose Injection USP in the DUPLEX® Drug Delivery System. Administration will occur once as a 30 minute IV infusion prior to surgery in adult subjects weighing \>/= 120 kg

Trial Locations (2)

31904

IACT Health - Roswell - IACT - HyperCore - PPDS, Columbus

73102

Hightower Clinical, LLC, Oklahoma City

All Listed Sponsors
lead

B. Braun Medical Inc.

INDUSTRY